Epidemiological Characteristics of Meningococcal Infection in Moscow

QR Code

Epidemiological Characteristics of Meningococcal Infection in Moscow

Aims. The purpose of this study was to identify current epidemiological features of meningococcal infection in Moscow.Materials and methods. Cases of invasive meningococcal disease in Moscow from 2014 to 2018 and the biomaterial from patients with an invasive meningococcal disease were analyzed.Resu...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. I. Gritsay, M. A. Koroleva, N. N. Fomkina, I. S. Koroleva
Format:	Article
Language:	Russian
Published:	Numikom LLC 2020-05-01
Series:	Эпидемиология и вакцинопрофилактика
Subjects:	meningococcal disease meningococcus epidemiology meningitis meningococcemia vaccination
Online Access:	https://www.epidemvac.ru/jour/article/view/982
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Level of Meningococcal Carriage and Genotyping of N. meningitidis Strains in the Group of Labor Migrants
by: M. A. Koroleva, et al.
Published: (2020-11-01)

Epidemiology of invasive meningococcal disease in Novosibirsk region during 1992–2015
by: I. Ya. Izvekova, et al.
Published: (2016-11-01)

Clinical and epidemiological aspects of generalized meningococcal infections in children and adolescents of Saint-Petersburg
by: Yu. V. Lobzin, et al.
Published: (2016-04-01)

The Emergence of a Ciprofloxacin-Resistant Non-Groupable Neisseria meningitidis Strain of the Clonal Complex ST-175 in the Russian Federation
by: M. A. Koroleva, et al.
Published: (2021-09-01)

The important lessons lurking in the history of meningococcal epidemiology
by: Ray Borrow, et al.
Published: (2024-12-01)

Serogroup B Protein Meningococcal Vaccines and the Formation of Immune Protection against Gonorrhea
by: N. N. Kostyukova, et al.
Published: (2024-07-01)

Meningococcal Infection in Novosibirsk: Changes in Epidemiology and Prevention Problems
by: I. Ya. Izvekova, et al.
Published: (2021-07-01)

The Susceptibility of Meningococci to the Antimicrobial Agents in Moscow 2006 - 2015
by: M. A. Koroleva, et al.
Published: (2016-06-01)

Epidemiological Features of Purulent Bacterial Meningitis in the Russian Federation at the Present Stage
by: M. A. Koroleva, et al.
Published: (2023-09-01)

Hemophilus meningitis – Current Aspects of Epidemiology and Prevention: a Descriptive Review
by: M. I. Gritsay, et al.
Published: (2024-01-01)

the course of a invasive meningococcal disease in a patient of military age from specific prophylaxis (clinical case)
by: V. V. Sharabkhanov, et al.
Published: (2020-06-01)

Safety and Immunogenicity of Meningococcal Groups A and C Polysaccharide Vaccine in Adults 18–60 years of age
by: V. V. Romanenko, et al.
Published: (2023-11-01)

World Experience in the Use Serogroup B Meningococcal Vaccines (literature review)
by: I. S. Koroleva, et al.
Published: (2022-01-01)

Epidemiological Manifestations of Purulent Bacterial Meningitis in the Russian Federation
by: M. A. Davydenko, et al.
Published: (2024-11-01)

Epidemiology and Regional Programs on Meningococcal Disease Prevention in Tyumen Region and Yamalo-Nenets Autonomous District
by: Olga A. Richkova, et al.
Published: (2020-06-01)

Meningococcal Urethritis: an additional Source of Meningococcal Disease?
by: N. N. Kostyukova, et al.
Published: (2020-07-01)

Meningococcal disease. Polysaccharide meningococcal vaccines. The historical aspects and the current state of vaccine development. Report 2
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Heart damage during meningococcal infection
by: A. A. Grishaeva, et al.
Published: (2024-12-01)

EPIDEMIOLOGY AND PREVENTION OF MENINGOCOCCAL DISEASE: A CRITICAL APPRAISAL OF VACCINE POLICIES
by: Marco AP Safadi, et al.
Published: (2012-02-01)

Meningococcal Vaccines of New Generations – the First 20 Years of Use
by: N. N. Kostyukova, et al.
Published: (2021-09-01)

Meningococcal infection in children: factors influencing outcome
by: O. V. Samodova, et al.
Published: (2019-10-01)

A case report: rehabilitation of a child after necrosis and amputations due to meningococcal infection
by: I.P. Zlepko, et al.
Published: (2025-04-01)

Epidemiological Aspects of Pneumococcal Meningitis in the Russian Federation
by: I. S. Koroleva, et al.
Published: (2016-10-01)

Evaluation of the potential economic effects in the increased vaccination against meningococcal infection based on real epidemiological data
by: S. V. Svetlichnaya, et al.
Published: (2023-08-01)

The Safety of 4-valent Meningococcal Conjugate Vaccine in Two Years Old Children: Prospective Cohort Study in Sakhalin Region
by: Oxana V. Solonina, et al.
Published: (2019-09-01)

Vaccination of Patients with Comorbid Conditions against Meningococcal and Pneumococcal Disease and Influenza during the COVID-19 Pandemic – New Aspects
by: M. P. Kostinov, et al.
Published: (2023-11-01)

Clinical Case of Repeated Generalized Infection and Meningitis in Immunocompetent Child
by: Mariya S. Vedyashkina, et al.
Published: (2021-03-01)

Cost-effectiveness of meningococcal vaccination of infants in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2021-12-01)

Epidemiological characteristics of invasive meningococcal disease and carriage prevalence of Neisseria meningitidis in the Xinjiang Uygur Autonomous Region, China, 2004–2023: a retrospective study
by: Halimubieke Nazhaerbieke, et al.
Published: (2025-07-01)

Past, present, and future policy considerations regarding meningococcal vaccination in the United States
by: Diana E. Clements, et al.
Published: (2024-12-01)

Clinical-epidemiological features of meningococcal infection in children during sporadic morbidity
by: G. P. Martynova, et al.
Published: (2015-07-01)

Clinical and epidemiological characteristics of meningococcal infection morbidity in Penza Region for the period 2007-2019
by: V. L. Melnikov, et al.
Published: (2021-10-01)

Safety of Combination of a Tetravalent Meningococcal Conjugate Vaccine Against Serogroups A, C, Y, W-135 With Other Vaccine Preparations: a Prospective Study of a Series of Cases Among Healthy Children and Children With Various Health Abnormalities
by: Leyla S. Namazova-Baranova, et al.
Published: (2017-06-01)

Generalized Meningococcal Disease in the Newborn: Clinical Case and Literature Review
by: Irina Ya. Izvekova
Published: (2023-05-01)

Estimation of the Potential Benefits of Meningococcal Vaccination in Children at 9 and 12 Months of Age Using a Predictive Mathematical Model
by: N. I. Briko, et al.
Published: (2020-11-01)

Dynamics (2014-2019) of Tetravalent Vaccines Against Meningococcal Infection Serogroups A, C, Y and W-135 Use: Prospective Study of Series of Cases Followed by the Monitoring of the Immunization Safety (Using the Conjugate Vaccine as the Example)
by: Diana V. Sutovskaya, et al.
Published: (2020-04-01)

CLINICAL-EPIDEMIOLOGICAL FEATURES AND OUTCOME OF GENERALIZED FORMS OF MENINGOCOCCAL INFECTION IN CHILDREN
by: G. P. Martynova, et al.
Published: (2017-10-01)

Meningococcemia aguda
by: Ana Maria Villa Escobar, et al.
Published: (2007-02-01)

Meningococcal disease. Meningococcal conjugate polysaccharide vaccines and new generation vaccines. Report 3
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Economic Burden of Invasive Meningococcal Infection in Children in the Republic of Belarus
by: E. N. Sergienko, et al.
Published: (2024-01-01)